Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. [electronic resource]
Producer: 20070119Description: 57-63 p. digitalISSN:- 0090-3493
- Administration, Inhalation
- Adrenergic beta-Agonists -- pharmacology
- Adult
- Albuterol -- analogs & derivatives
- Analysis of Variance
- Bronchoalveolar Lavage Fluid -- chemistry
- Bronchodilator Agents -- pharmacology
- Factor VIIa -- analysis
- Fibrinolysis -- drug effects
- Humans
- Inflammation
- Lipopolysaccharides -- adverse effects
- Lung -- drug effects
- Lung Diseases -- drug therapy
- Macrophages, Alveolar -- drug effects
- Male
- Plasminogen Activator Inhibitor 1 -- analysis
- Plasminogen Activators -- analysis
- Protein C -- analysis
- Salmeterol Xinafoate
- Single-Blind Method
- Thrombomodulin -- analysis
- Thromboplastin -- analysis
- Tissue Plasminogen Activator -- analysis
- Urokinase-Type Plasminogen Activator -- analysis
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.